AI/ML Innovations Inc. (CSE:AIML)
0.0450
0.00 (0.00%)
Oct 9, 2026, 9:30 AM EST
AI/ML Innovations Revenue
AI/ML Innovations had revenue of 2.00K CAD in the quarter ending July 31, 2026, a decrease of -95.17%. This brings the company's revenue in the last twelve months to 43.69K, down -73.93% year-over-year. In the fiscal year ending April 30, 2026, AI/ML Innovations had annual revenue of 83.06K, down -50.36%. That makes AI/ML Innovations the 46,800th largest company in the world by revenue and 1,097th in Canada.
Revenue (ttm)
43.69K
Revenue Growth
-73.93%
P/S Ratio
307.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 83.06K | -84.25K | -50.36% |
| Apr 30, 2025 | 167.31K | -432.83K | -72.12% |
| Apr 30, 2024 | 600.14K | 112.63K | 23.10% |
| Apr 30, 2023 | 487.50K | 422.10K | 645.32% |
| Apr 30, 2022 | 65.41K | - | - |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Victory Square Technologies | 78.43M |
| NexgenRx | 19.34M |
| Comprehensive Healthcare Systems | 6.20M |
| Seegnal | 1.93M |
| KDA Group | 419.13K |
| Principal Technologies | 370.42K |
| Apptly Health Technologies | 100.58K |
AI/ML Innovations News
- 7 days ago - AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement - Accesswire
- 8 days ago - AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services - Accesswire
- 10 days ago - AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield(TM) Clinical Pilots - Accesswire
- 18 days ago - AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform - Accesswire
- 25 days ago - AI/ML Innovations Inc. Closes Final Tranche of Private Placement - Accesswire
- 5 weeks ago - AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs - Accesswire
- 6 weeks ago - AI/ML Innovations Inc. Closes First Tranche of Private Placement - Accesswire
- 7 weeks ago - AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield(TM) Pilot - Accesswire